Subclinical carotid atherosclerosis in patients with psoriatic arthritis.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 18759318)

Published in Arthritis Rheum on September 15, 2008

Authors

Lai-Shan Tam1, Qing Shang, Edmund K Li, Brian Tomlinson, Tanya T W Chu, Martin Li, Ying-Ying Leung, Lai-Wa Kwok, Kong-Chiu Wong, Tena K Li, Tracey Yu, Tracy Y Zhu, Emily W Kun, Gabriel W Yip, Cheuk-Man Yu

Author Affiliations

1: The Prince of Wales Hospital and The Chinese University of Hong Kong, Hong Kong, China. tamls_813@yahoo.com

Articles citing this

The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T (2010) 1.15

Evaluation of subclinical atherosclerosis in Egyptian psoriatic patients. J Saudi Heart Assoc (2013) 0.92

Cardiovascular risk in patients with psoriatic arthritis. Int J Rheumatol (2012) 0.88

Management of cardiovascular complications in systemic lupus erythematosus. Int J Clin Rheumtol (2010) 0.85

Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.85

Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. Arthritis Res Ther (2015) 0.79

Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int (2015) 0.78

Carotid intima-media thickness in patients with mild or moderate psoriasis. Postepy Dermatol Alergol (2016) 0.78

Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol (2014) 0.78

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int (2016) 0.77

The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus (2009) 0.77

Cardiovascular co-morbidity in patients with rheumatic diseases. Arthritis Res Ther (2011) 0.77

Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients. Clin Rheumatol (2013) 0.76

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Arthritis Res Ther (2017) 0.75

Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center. J Transl Med (2016) 0.75

Association Between Psoriasis and Subclinical Atherosclerosis: A Meta-Analysis. Medicine (Baltimore) (2016) 0.75

The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis. Arthritis Res Ther (2016) 0.75

Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2. Sci Rep (2016) 0.75

Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis. Eur J Rheumatol (2017) 0.75

Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries. BMC Cardiovasc Disord (2012) 0.75

Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Ther Adv Musculoskelet Dis (2015) 0.75

[Development of morbidity and mortality in patients with spondyloarthritis]. Z Rheumatol (2011) 0.75

Articles by these authors

Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation (2008) 7.11

Human chromosome 7: DNA sequence and biology. Science (2003) 3.02

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol (2011) 2.78

Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr (2008) 2.42

Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol (2007) 2.18

Cardiac resynchronization therapy: Part 1--issues before device implantation. J Am Coll Cardiol (2005) 2.06

Discovery of human inversion polymorphisms by comparative analysis of human and chimpanzee DNA sequence assemblies. PLoS Genet (2005) 2.05

Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. J Am Coll Cardiol (2005) 1.98

Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol (2005) 1.85

Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J (2011) 1.83

Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure. J Am Coll Cardiol (2007) 1.73

Diagnostic value of magnetocardiography in coronary artery disease and cardiac arrhythmias: a review of clinical data. Int J Cardiol (2013) 1.64

Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J (2011) 1.61

Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern. J Rheumatol (2010) 1.59

Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia. J Rheumatol (2003) 1.58

Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr (2004) 1.58

miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol Ther (2012) 1.56

Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2008) 1.54

Left atrial regional phasic strain, strain rate and velocity by speckle-tracking echocardiography: normal values and effects of aging in a large group of normal subjects. Int J Cardiol (2013) 1.52

The confluent balloon technique--two cases illustrating a novel method to achieve rapid wire crossing of chronic total occlusion during retrograde approach percutaneous coronary intervention. J Invasive Cardiol (2009) 1.52

Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy. Eur Heart J (2010) 1.50

Right ventricular long-axis response to different chronic loading conditions: its relevance to clinical symptoms. Int J Cardiol (2012) 1.50

OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet Genomics (2008) 1.50

Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol (2005) 1.50

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. J Hypertens (2002) 1.49

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut (2011) 1.46

Impact of a dedicated training program on the reproducibility of systolic dyssynchrony measures using tissue Doppler imaging. J Am Soc Echocardiogr (2011) 1.46

Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure. Eur Heart J (2006) 1.46

The beneficial effects of Tai Chi Chuan on blood pressure and lipid profile and anxiety status in a randomized controlled trial. J Altern Complement Med (2003) 1.43

Association of the D8S282 marker near the lipoprotein lipase gene locus with systolic blood pressure in healthy Chinese subjects. J Hypertens (2002) 1.38

Images in cardivascular medicine. Detection of large aneurysm of Vieussens' arterial ring after abnormal shadow on chest radiography. Circulation (2009) 1.24

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug Discov Today (2010) 1.24

Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens (2005) 1.23

The impact of flare on disease costs of patients with systemic lupus erythematosus. Arthritis Rheum (2009) 1.21

Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv (2011) 1.20

Total antioxidant and ascorbic acid content of fresh fruits and vegetables: implications for dietary planning and food preservation. Br J Nutr (2002) 1.19

Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol (2002) 1.18

The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest (2004) 1.17

Quantitative analysis of mitral valve morphology in mitral valve prolapse with real-time 3-dimensional echocardiography: importance of annular saddle shape in the pathogenesis of mitral regurgitation. Circulation (2012) 1.16

Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol (2009) 1.16

100 or 30 years after Janeway or Bartter, Healthwatch helps avoid 'flying blind'. Biomed Pharmacother (2004) 1.15

N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients. J Am Soc Nephrol (2006) 1.14

Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes. Diabetes (2003) 1.13

Protective effects of trilinolein extracted from panax notoginseng against cardiovascular disease. Acta Pharmacol Sin (2002) 1.13

Strain rate imaging differentiates transmural from non-transmural myocardial infarction: a validation study using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol (2005) 1.10

Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br J Clin Pharmacol (2004) 1.10

Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum (2004) 1.10

Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. Arthritis Res Ther (2012) 1.09

Quantification of left ventricular regional myocardial function using two-dimensional speckle tracking echocardiography in healthy volunteers--a multi-center study. Int J Cardiol (2012) 1.08

Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). Vaccine (2006) 1.08

Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2011) 1.07

Cost-of-illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res (Hoboken) (2011) 1.06

New oral anticoagulants in acute coronary syndromes: what does a meta-analysis tell us? JAMA Intern Med (2013) 1.06

Lessons from the severe acute respiratory syndrome outbreak in Hong Kong. Emerg Infect Dis (2003) 1.06

Ezetimibe treatment should be considered for patients with sitosterolemia. Pediatr Nephrol (2014) 1.06

Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary artery disease: the reality? Eur J Prev Cardiol (2013) 1.05

Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clin Chem (2007) 1.03

Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as hypertension susceptibility genes in Han Chinese with a genome-wide gene-based association study. PLoS One (2012) 1.03

Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics (2004) 1.02

Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther (2010) 1.02

Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol (2013) 1.02

Quality of life in patients with coronary heart disease-I: assessment tools. Health Qual Life Outcomes (2003) 1.02

Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol (2009) 1.00

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients. Pharmacogenomics (2013) 0.99

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis? Rheumatology (Oxford) (2009) 0.98

Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus. Clin Dev Immunol (2012) 0.98

Approaching regional left atrial function by tissue Doppler velocity and strain imaging. Europace (2008) 0.98

Effects of Tai Chi and resistance training on cardiovascular risk factors in elderly Chinese subjects: a 12-month longitudinal, randomized, controlled intervention study. Clin Endocrinol (Oxf) (2005) 0.98

Left ventricular systolic asynchrony after acute myocardial infarction in patients with narrow QRS complexes. Am Heart J (2005) 0.97

An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol (2005) 0.97

Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart (2010) 0.97

The role of repeating optimization of atrioventricular interval during interim and long-term follow-up after cardiac resynchronization therapy. Int J Cardiol (2007) 0.96

Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong hospital audit study. Value Health (2008) 0.96

Genetic mutations in non-syndromic deafness patients of Uyghur and Han Chinese ethnicities in Xinjiang, China: a comparative study. J Transl Med (2011) 0.95

A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study). Curr Med Res Opin (2007) 0.95

Measuring job stress and family stress in Chinese working women: a validation study focusing on blood pressure and psychosomatic symptoms. Women Health (2004) 0.95

Assessment of the effect of cardiac resynchronization therapy on intraventricular mechanical synchronicity by regional volumetric changes. Am J Cardiol (2005) 0.95

A genome-wide linkage and association scan reveals novel loci for hypertension and blood pressure traits. PLoS One (2012) 0.94

Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase. Cardiovasc Res (2010) 0.94

Correlation of large artery intracranial occlusive disease with carotid intima-media thickness and presence of carotid plaque. Stroke (2012) 0.94

Oxidized LDL at low concentration promotes in-vitro angiogenesis and activates nitric oxide synthase through PI3K/Akt/eNOS pathway in human coronary artery endothelial cells. Biochem Biophys Res Commun (2011) 0.93

CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol (2009) 0.93

Optimal use of echocardiography in cardiac resynchronisation therapy. Heart (2007) 0.93

Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis (2009) 0.93

Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). Am J Cardiol (2009) 0.93

Effect of age and gender on left ventricular rotation and twist in a large group of normal adults--a multicenter study. Int J Cardiol (2012) 0.92

Compliance with the Dietary Approaches to Stop Hypertension (DASH) diet: a systematic review. PLoS One (2013) 0.92

Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong. Rheumatology (Oxford) (2009) 0.92

Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis. Rheumatology (Oxford) (2010) 0.92

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects. Clin Pharmacol Ther (2005) 0.92

Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens (2010) 0.91